Ambagon Therapeutics

Ambagon Therapeutics

Verified
Biotechnology company that is developing cancer molecule therapeutics.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$340—510m (Dealroom.co estimates Jan 2022.)
California United States (HQ), Eindhoven Noord-Brabant (founding location)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

$0.0

round
investor

$0.0

round
*

$85.0m

Series A
Total Funding000k

Recent News about Ambagon Therapeutics

Edit